Reuters logo
BRIEF-Intra-Cellular starts enrollment in ITI-214 clinical trial in patients with Parkinson’s disease
2017年10月3日 / 下午12点30分 / 18 天前

BRIEF-Intra-Cellular starts enrollment in ITI-214 clinical trial in patients with Parkinson’s disease

Oct 3 (Reuters) - Intra-cellular Therapies Inc

* Intra-Cellular therapies announces commencement of enrollment of a clinical trial evaluating ITI-214 in patients with Parkinson’s disease Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below